Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

about

Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.Induction of immunity following vaccination with a chemically attenuated malaria vaccine correlates with persistent antigenic stimulation.Malaria Vaccines: Recent Advances and New Horizons

P2860

Q47106697-63DFFAC6-CBC2-47F1-81A3-11F8B1143B31 Q55403419-305A7666-B60F-4FA6-93F4-4822F31A742B Q56362064-1551B451-C087-4668-BF6A-4967BE571ADA

P2860

Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

Item

http://www.wikidata.org/entity/Q39259814

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

@en

Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

@nl

type

Item

label

Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

@en

Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

@nl

prefLabel

Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

@en

Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

@nl

P1476

Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

@en

P2093

Amber I Raja

http://www.w3.org/2001/XMLSchema#string

P2860

The position of mefloquine as a 21st century malaria chemoprophylaxis

Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial

Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.

Cross-species malaria immunity induced by chemically attenuated parasites.

Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria.

Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunization

Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines.

Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites.

Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans

Chemical attenuation of Plasmodium berghei sporozoites induces sterile immunity in mice.

P31

scholarly article

P356

10.1128/IAI.00062-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael F. Good

Danielle I Stanisic

P577

2017-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28438976

http://www.w3.org/2001/XMLSchema#string

P921

malaria

P932

5478957

http://www.w3.org/2001/XMLSchema#string

Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

about

P2860

P2860

Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932